Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMoneysupermarket.Com Share News (MONY)

Share Price Information for Moneysupermarket.Com (MONY)

Share Price is delayed by 15 minutes
Get Live Data
185.20    -0.80 (-0.43%)
Bid:
185.60
Ask:
186.10
Spread: 0.50 (0.269%)
Market Cap: £955.06m
MONY Live PriceLast checked at - London Stock Exchange

Intraday Moneysupermarket.Com Share Chart

Wednesday broker round-up

Wed, 04th Dec 2019 11:19
(Sharecast News) - Moneysupermarket: RBC Capital Markets downgrades to underperform with a target price of 300p.

Centrica: Citigroup upgrades to buy with a target price of 100p.

Tekmar Group: Berenberg reiterates buy with a target price of 180p.

Ferguson: Deutsche Bank reiterates buy with a target price of 7,650p.

Admiral Group: Barclays reiterates overweight with a target price of 2,356p.

Aviva: Barclays downgrades to equal weight with a target price of 461p.

Prudential: Barclays reiterates overweight with a target price of 1,725p.

Bovis Homes: UBS reiterates neutral with a target price of 1,170p.

Segro: RBC Capital Markets downgrades to underperform with a target price of 725p.

Rightmove: JP Morgan reiterates underweight with a target price of 433p.

Severn Trent: Goldman Sachs reiterates sell with a target price of 1,986p.

Related News

Prologis proposal 'inadequate, opportunistic and one-sided', says Segro
4 hours ago

Prologis proposal 'inadequate, opportunistic and one-sided', says Segro

(Sharecast News) - Segro said on Tuesday that it was confident in its standalone investment case as it accused Prologis of trying to buy the company "...

Segro calls Prologis bid "inadequate, opportunistic and one-sided"
4 hours ago

Segro calls Prologis bid "inadequate, opportunistic and one-sided"

(Alliance News) - Segro PLC on Tuesday said it continues to reject a possible bid approach from Prologis Inc after the US firm outlined the strategic ...

LONDON BROKER RATINGS: UBS, RBC and Citi cut easyJet; UBS lowers Mondi
7 hours ago

LONDON BROKER RATINGS: UBS, RBC and Citi cut easyJet; UBS lowers Mondi

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday:

Moneysupermarket.Com News

Mony confident for year after "good growth" in first four months
30 Apr 2026

Mony confident for year after "good growth" in first four months

(Alliance News) - Mony Group PLC on Thursday reiterated its full-year guidance after a "solid" start to 2026.

LONDON BROKER RATINGS: Exane BNP initiates coverage; UBS cuts SSP
28 Apr 2026

LONDON BROKER RATINGS: Exane BNP initiates coverage; UBS cuts SSP

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday:

WINNERS & LOSERS: AO World backs view; B&M shares decline
10 Apr 2026

WINNERS & LOSERS: AO World backs view; B&M shares decline

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday.

WINNERS & LOSERS: Metlen Energy takes hit from annual results delay
27 Mar 2026

WINNERS & LOSERS: Metlen Energy takes hit from annual results delay

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday.

Jefferies upgrades Mony to 'buy', says AI-driven fears are misplaced
27 Mar 2026

Jefferies upgrades Mony to 'buy', says AI-driven fears are misplaced

(Sharecast News) - Jefferies upgraded Mony Group to 'buy' from 'hold' on Friday and lifted the price target to 230p from 205p, citing an attractive en...

LONDON BROKER RATINGS: BofA raises Berkeley; UBS raises Savills
27 Mar 2026

LONDON BROKER RATINGS: BofA raises Berkeley; UBS raises Savills

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday day:

LONDON BRIEFING: UK retail sales fall; GSK drug accepted for review
27 Mar 2026

LONDON BRIEFING: UK retail sales fall; GSK drug accepted for review

(Alliance News) - UK retail sales fell in the month of February but by less than expected, while GSK and AstraZeneca hailed positive clinical and regu...